• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考拉宁和万古霉素纸片药敏试验的评估

Evaluation of teicoplanin and vancomycin disk susceptibility tests.

作者信息

Barry A L, Thornsberry C, Jones R N

出版信息

J Clin Microbiol. 1986 Jan;23(1):100-3. doi: 10.1128/jcm.23.1.100-103.1986.

DOI:10.1128/jcm.23.1.100-103.1986
PMID:2939101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC268579/
Abstract

Disk tests with two glycopeptide antibiotics, teicoplanin and vancomycin, were evaluated, and MICs were compared with those of fusidic acid and coumermycin. For tests with 30-micrograms vancomycin disks, we recommend modification of the current zone size standards to less than or equal to 10 mm for resistant and greater than or equal 15 mm for susceptible. For teicoplanin disk tests, 30-micrograms disks are recommended, with zone size interpretive standards of less than or equal to 10 and greater than or equal 14 mm. Since no resistant clinical isolates are available at this time, susceptibility testing of either drug is rarely necessary, and zone size standards are tentative.

摘要

对两种糖肽类抗生素替考拉宁和万古霉素进行了纸片试验,并将其最低抑菌浓度(MIC)与夫西地酸和香豆霉素的MIC进行了比较。对于含30微克万古霉素纸片的试验,我们建议将当前的抑菌圈大小标准修改为:耐药时小于或等于10毫米,敏感时大于或等于15毫米。对于替考拉宁纸片试验,建议使用30微克的纸片,抑菌圈大小的解释标准为小于或等于10毫米和大于或等于14毫米。由于目前没有耐药的临床分离株,这两种药物的药敏试验很少有必要进行,抑菌圈大小标准是暂定的。

相似文献

1
Evaluation of teicoplanin and vancomycin disk susceptibility tests.替考拉宁和万古霉素纸片药敏试验的评估
J Clin Microbiol. 1986 Jan;23(1):100-3. doi: 10.1128/jcm.23.1.100-103.1986.
2
Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.香豆霉素的抗菌活性及使用5微克和15微克药敏纸片进行纸片扩散法试验的建议
Diagn Microbiol Infect Dis. 1987 May;7(1):77-82. doi: 10.1016/0732-8893(87)90075-7.
3
In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.卡芦莫南与香豆霉素、替考拉宁、氟氯西林和万古霉素的体外相互作用。
Chemioterapia. 1987 Jun;6(2 Suppl):117-8.
4
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.替考拉宁药敏试验的质量控制限度及纸片扩散法解释标准的确认
J Clin Microbiol. 1987 Sep;25(9):1812-4. doi: 10.1128/jcm.25.9.1812-1814.1987.
5
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.达托霉素和替考拉宁对溶血葡萄球菌和表皮葡萄球菌的活性,包括药敏试验建议的评估。
Antimicrob Agents Chemother. 1989 Apr;33(4):585-8. doi: 10.1128/AAC.33.4.585.
6
In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.替考拉宁、万古霉素、A16686、克林霉素、红霉素和夫西地酸对厌氧菌的体外活性。
Singapore Med J. 1990 Feb;31(1):56-8.
7
Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.万古霉素和替考拉宁单独使用或与夫西地酸或阿米卡星联合使用对耐甲氧西林葡萄球菌的作用。
J Chemother. 1997 Feb;9(1):5-8. doi: 10.1179/joc.1997.9.1.5.
8
In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.替考拉宁和万古霉素对来自人类临床及兽医领域的革兰氏阳性菌的体外活性。
APMIS. 1992 Jun;100(6):543-52.
9
Antibacterial activity of coumermycin alone and in combination with other antibiotics.香豆霉素单独及与其他抗生素联合使用时的抗菌活性。
Antimicrob Agents Chemother. 1984 Jun;25(6):687-9. doi: 10.1128/AAC.25.6.687.
10
Diffusion of teicoplanin and vancomycin in agar.替考拉宁和万古霉素在琼脂中的扩散
Diagn Microbiol Infect Dis. 1992 Mar-Apr;15(3):253-8. doi: 10.1016/0732-8893(92)90121-9.

引用本文的文献

1
Methicillin-resistant Staphylococcus aureus in Zimbabwe.津巴布韦的耐甲氧西林金黄色葡萄球菌
Ghana Med J. 2016 Jun;50(2):68-71. doi: 10.4314/gmj.v50i2.3.
2
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.由对万古霉素敏感性降低的革兰氏阳性菌引起的眼内炎:文献综述与治疗选择
Br J Ophthalmol. 2016 Apr;100(4):446-52. doi: 10.1136/bjophthalmol-2015-307722. Epub 2015 Dec 23.
3
Magnetic microsphere-based methods to study the interaction of teicoplanin with peptides and bacteria.基于磁性微球的方法研究替考拉宁与肽和细菌的相互作用。
Anal Bioanal Chem. 2008 Nov;392(5):877-86. doi: 10.1007/s00216-008-2327-y. Epub 2008 Aug 21.
4
Low-level vancomycin resistance in Clostridium innocuum.无害梭菌中的低水平万古霉素耐药性。
J Clin Microbiol. 1998 Jun;36(6):1767-8. doi: 10.1128/JCM.36.6.1767-1768.1998.
5
Recovery of resistant enterococci during vancomycin prophylaxis.万古霉素预防期间耐万古霉素肠球菌的恢复情况。
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
6
Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations.脂肽抗生素LY146032的抗菌活性与谱,包括药敏试验建议。
Antimicrob Agents Chemother. 1987 Apr;31(4):625-9. doi: 10.1128/AAC.31.4.625.
7
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.替考拉宁药敏试验的质量控制限度及纸片扩散法解释标准的确认
J Clin Microbiol. 1987 Sep;25(9):1812-4. doi: 10.1128/jcm.25.9.1812-1814.1987.
8
Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.用于检测肠球菌对万古霉素耐药性的纸片扩散法存在的问题。
J Clin Microbiol. 1989 Sep;27(9):2140-2. doi: 10.1128/jcm.27.9.2140-2142.1989.
9
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.耐万古霉素粪肠球菌的体外药敏研究。
Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91. doi: 10.1128/AAC.33.9.1588.
10
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.达托霉素和替考拉宁对溶血葡萄球菌和表皮葡萄球菌的活性,包括药敏试验建议的评估。
Antimicrob Agents Chemother. 1989 Apr;33(4):585-8. doi: 10.1128/AAC.33.4.585.

本文引用的文献

1
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.替考拉宁,一种来自新种游动放线菌的新型抗生素。
Antimicrob Agents Chemother. 1984 Dec;26(6):917-23. doi: 10.1128/AAC.26.6.917.
2
In vitro activity and human pharmacokinetics of teicoplanin.替考拉宁的体外活性及人体药代动力学
Antimicrob Agents Chemother. 1984 Dec;26(6):881-6. doi: 10.1128/AAC.26.6.881.
3
Teicoplanin.替考拉宁
J Antimicrob Chemother. 1984 Nov;14(5):441-5.
4
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.替考拉宁、夫西地酸、氟氯西林、磷霉素和万古霉素对耐甲氧西林金黄色葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1984 Aug;26(2):268-9. doi: 10.1128/AAC.26.2.268.
5
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).替考拉宁,来自新种游动放线菌(Actinoplanes teichomyceticus nov. sp.)的新型抗生素。IV. 替考拉宁(替考普肽)各组分的分离与特性分析
J Antibiot (Tokyo). 1984 Jun;37(6):615-20. doi: 10.7164/antibiotics.37.615.
6
In vitro activity of teichomycin compared with those of other antibiotics.替考霉素与其他抗生素的体外活性比较。
Antimicrob Agents Chemother. 1983 Sep;24(3):425-8. doi: 10.1128/AAC.24.3.425.
7
Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids.替考拉宁与其他抗生素对JK类白喉杆菌的体外活性比较
Antimicrob Agents Chemother. 1983 Aug;24(2):145-6. doi: 10.1128/AAC.24.2.145.
8
Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.替考霉素:与其他抗生素相比的体外和体内评价
J Antimicrob Chemother. 1983 May;11(5):419-25. doi: 10.1093/jac/11.5.419.
9
In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.替考霉素A2与青霉素和万古霉素相比对革兰氏阳性球菌的体外活性。
Eur J Clin Microbiol. 1982 Oct;1(5):278-81. doi: 10.1007/BF02019971.